Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · Real-Time Price · USD
0.2120
-0.0028 (-1.30%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Protagenic Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-5.53-5-3.56-4.52-2.55
Upgrade
Depreciation & Amortization
0.050.030-0
Upgrade
Other Amortization
-0.090.110.430.15
Upgrade
Loss (Gain) From Sale of Investments
-0.050.630.050-
Upgrade
Stock-Based Compensation
0.920.670.861.521.65
Upgrade
Other Operating Activities
-0.08---0.08-0.25
Upgrade
Change in Accounts Payable
0.37-0.03-0.090.34-0.2
Upgrade
Change in Other Net Operating Assets
0.1-0.090.63-0.48-0.16
Upgrade
Operating Cash Flow
-4.22-3.7-1.99-2.8-1.35
Upgrade
Capital Expenditures
--0.15-0--
Upgrade
Investment in Securities
2.84.931.6-9.91-
Upgrade
Investing Cash Flow
2.84.781.6-9.91-
Upgrade
Short-Term Debt Issued
---0.1-
Upgrade
Long-Term Debt Issued
----1.33
Upgrade
Total Debt Issued
---0.11.33
Upgrade
Short-Term Debt Repaid
----0.1-
Upgrade
Total Debt Repaid
----0.1-
Upgrade
Net Debt Issued (Repaid)
----1.33
Upgrade
Issuance of Common Stock
1.96--12.58-
Upgrade
Other Financing Activities
-----0.1
Upgrade
Financing Cash Flow
1.96--12.581.22
Upgrade
Foreign Exchange Rate Adjustments
000.070-0
Upgrade
Net Cash Flow
0.551.07-0.33-0.13-0.13
Upgrade
Free Cash Flow
-4.22-3.85-2-2.8-1.35
Upgrade
Free Cash Flow Per Share
-0.86-0.89-0.46-0.76-0.52
Upgrade
Levered Free Cash Flow
-2.2-2.47-0.73-1.29-0.65
Upgrade
Unlevered Free Cash Flow
-2.2-2.49-0.75-1.41-0.65
Upgrade
Change in Net Working Capital
-0.390.21-0.610.340.71
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q